JOURNAL REVIEWED: British Journal of Ophthalmology
Latest Contribution
A prospective trial of adjuvant therapy for high-risk melanoma
Patients diagnosed with iris, ciliary body or choroidal melanoma of high-risk tumour cytogenetics (monosomy 3>/= 20% of cells), were treated with adjuvant low-dose dacarbacine (DTIC) and interferon –alpha-2b (IFNA-2b), following primary treatment (enucleation, brachytherapy or resection). DTIC was given intravenously...
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD
This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...
Van Herick Plus
This a consecutive cross-sectional study of 95 phakic patients over the age of 40-years-old. By applying a short, vertical slit beam, the inferior angle at the scleral-limbal junction at 6 o’clock position was evaluated, photographed and assessed by a ratio...
